Refine by MP, party, committee, province, or result type.

Results 16-30 of 106
Sorted by relevance | Sort by date: newest first / oldest first

Justice committee  But not every case will necessarily get reported in the database.

April 9th, 2019Committee meeting

Richard Elliott

Justice committee  Yes. I'm not sure that the Justice Canada report says that the majority of those cases involved those kinds of factors. Certainly, that would not be the case based on the data we have in our database. I would also underscore that this is why it's really important that our applic

April 9th, 2019Committee meeting

Richard Elliott

Justice committee  Thank you to the members of the committee. I want to take a moment to thank Alex for sharing those stories of people living with HIV, and what is some really incredible and groundbreaking research, and really important in underscoring to the members of the committee why this is

April 9th, 2019Committee meeting

Richard Elliott

International Trade committee  The answer is no. I think it's worth noting that in the CETA negotiations one of the major areas of concern has been the investment chapter, and that has been one of the major stumbling blocks, particularly in Europe, because of the potential negative consequences of it. I'm n

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  Yes. I was going to say harmonization can be a good thing, but we shouldn't assume that it is. If you harmonize down to the lowest common denominator and you sacrifice to the public interest, that's not good harmonization. If Jimmy jumps off the bridge, it doesn't mean we should

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  Thank you. I think we can debate a bit what would constitute a fair scenario. I think it's fair to say that all WTO members agreed on the TRIPS agreement, the agreement on intellectual property rights, back in 1994. All of the discussion now globally, except in the context of t

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  Certainly. Thank you for the question. There are others from the industry here, I think, who can also speak to direct experience of how those things operate in practice, those linkage regulations. The existing notice of compliance regulations under the Food and Drugs Act allow f

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  Yes. I have two quick points. It's important to remember that one of the commitments made by the originator pharmaceutical industry when NAFTA was adopted with more stringent IP provisions and less policy space for Canada was that they would commit to 10% of sales spent annually

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  â€”the extension of patent terms beyond what already exists, which will apply in both Canadian and other TPP member states; the locking in of our linkage regulations that tie marketing approval of generics to claims of patent infringement by brand-name companies; and provision that

May 31st, 2016Committee meeting

Richard Elliott

International Trade committee  Thank you, Mr. Chair. Thank you to the committee for the invitation to appear. I am the head of an organization that works for the human rights of people living with HIV and of communities particularly affected by HIV, both in Canada and internationally. We are also a member

May 31st, 2016Committee meeting

Richard Elliott

Industry committee  That's right. I will continue in English, if I may. The majority of the 5.2 million people who are receiving HIV treatment now in the developing world are on generic medications because that's what has made it affordable. That's how we've made the progress Mr. Lake was referrin

October 21st, 2010Committee meeting

Richard Elliott

Industry committee  We haven't seen that so far. You would have to ask them.

October 21st, 2010Committee meeting

Richard Elliott

Industry committee  Thank you. Let me just address two points quickly, to get back to the question that a few people posed. The first point is the issue of diversion of medicines, which of course we don't want to see happen. Dr. Kilby put it very well. We have to take some risks here. The legislat

October 21st, 2010Committee meeting

Richard Elliott

Industry committee  A few weeks ago, the Prime Minister announced to the UN what Canada's contribution was. I can't remember the exact figure, but I think it was five dollars per Canadian more or less. So you can do the math.

October 21st, 2010Committee meeting

Richard Elliott

Industry committee  Definitely. In our assessment, and in the assessment of those who've tried to use the current system and the experts who have looked at it, if we make these changes, we dramatically increase the chances of it being used again to get medicines out the door. I don't think it's pre

October 21st, 2010Committee meeting

Richard Elliott